As of Jan 17, 2025, Zimmer Biomet Holdings, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $160.7. This suggests it may be undervalued by 46.7% compared to its current price of around $109.6, using a WACC of 7.4% and growth rates of 3.0%.
As of Jan 17, 2025, Zimmer Biomet Holdings, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 7.4%.
As of Jan 17, 2025, Zimmer Biomet Holdings, Inc.'s Enterprise Value (EV) is approximately $38.1B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.